Studies have shown that FAT3 was a key mutation gene in multiple tumors, including ovarian cancer, breast cancer (23), lung adenocarcinoma (24), and pancreatic acinar cell carcinoma (25). This evidence concerns the gene FAT3 and breast carcinoma.